Metformin Promotes Axon Regeneration after Spinal Cord Injury through Inhibiting Oxidative Stress and Stabilizing Microtubule

Abstract EN

Spinal cord injury (SCI) is a devastating disease that may lead to lifelong disability.

Thus, seeking for valid drugs that are beneficial to promoting axonal regrowth and elongation after SCI has gained wide attention.

Metformin, a glucose-lowering agent, has been demonstrated to play roles in various central nervous system (CNS) disorders.

However, the potential protective effect of metformin on nerve regeneration after SCI is still unclear.

In this study, we found that the administration of metformin improved functional recovery after SCI through reducing neuronal cell apoptosis and repairing neurites by stabilizing microtubules via PI3K/Akt signaling pathway.

Inhibiting the PI3K/Akt pathway with LY294002 partly reversed the therapeutic effects of metformin on SCI in vitro and vivo.

Furthermore, metformin treatment weakened the excessive activation of oxidative stress and improved the mitochondrial function by activating the nuclear factor erythroid-related factor 2 (Nrf2) transcription and binding to the antioxidant response element (ARE).

Moreover, treatment with Nrf2 inhibitor ML385 partially abolished its antioxidant effect.

We also found that the Nrf2 transcription was partially reduced by LY294002 in vitro.

Taken together, these results revealed that the role of metformin in nerve regeneration after SCI was probably related to stabilization of microtubules and inhibition of the excessive activation of Akt-mediated Nrf2/ARE pathway-regulated oxidative stress and mitochondrial dysfunction.

Overall, our present study suggests that metformin administration may provide a potential therapy for SCI.